• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Acepromazine Maleate

Acepromazine Maleate

Product ID A0916
Cas No. 3598-37-6
Purity ≥99%
Product Unit SizeCostQuantityStock
25 mg $133.00 In stock
100 mg $255.00 In stock
250 mg $408.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Acepromazine is a phenothiazine derivative antipsychotic agent related to chlorpromazine. Acepromazine maleate is primarily used in veterinary field as a sedative and antiemetic, although it has previously been used as an antipsychotic in humans. Acepromazine acts as an antagonist at D1/2 and 5-HT1A/2A receptors; it prevents sudden cardiac death in animal models of status epilepticus and reduces vasopressor activity of dopamine during anesthesia. Acepromazine may also inhibit ABCG2, a transport protein whose overexpression in tumors is associated with drug resistance.

Product Info

Cas No.

3598-37-6

Purity

≥99%

Formula

C19H22N2OS • C4H4O4

Formula Wt.

442.53

IUPAC Name

1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone

Solubility

Water (>10 mg/mL)

Appearance

Yellow crystals

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

A0916 MSDS PDF

Info Sheet

A0916 Info Sheet PDF

References

Mersich I, Bishop R, Yucupicio S, et al. Decreased circulating red cell mass induced by intravenous acepromazine administration alters viscoelastic parameters and traditional plasma coagulation testing results in healthy horses. Animals (Basel). 2024 Oct 28;14(21):3102. PMID: 39518825.

Monteiro ER, Teixeira Neto FJ, et al. Effects of acepromazine on the cardiovascular actions of dopamine in anesthetized dogs. Vet Anaesth Analg. 2007 Sep;34(5):312-21. PMID: 17686118.

Harrigan T, Bureau YR, Persinger MA, et al. Prevention of sudden cardiac death by the atypical neuroleptic acepromazine following status epilepticus in rats. Life Sci. 1994;54(24):PL457-62. PMID: 8196501.

Wirth W, Goesswald R, Vater W. On the pharmacology of acylated phenothiazine derivatives. Arch Int Pharmacodyn Ther. 1959 Dec 1;123:78-114. PMID: 13845370.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • A5276

    Angiotensin I, human

    Endogenous peptide, cleavage product of angiote...

    ≥98%
  • O486179

    Omeprazole Impurity C

    Impurity of omeprazole

    ≥99%
  • D5897

    Doxycycline Hyclate

    Tetracycline; protein translation inhibitor, MM...

    ≥97%
  • B3200

    BI-2536

    PLK1 inhibitor.

    ≥98%
  • T3098

    Thymosin β-4 Acetate

    Endogenous peptide; actin polymerization inhibi...

    ≥95%
  • S0045

    Salbutamol Sulfate

    β2-adrenergic agonist.

    ≥98%
  • G2969

    Growth Hormone Releasing Hexapeptide

    Synthetic peptide hormone, met-enkephalin analo...

    ≥95%
  • A4606

    Albendazole

    Benzimidazole; microtubule polymerization inhib...

    ≥95%
  • B5075

    BMS-708163

    γ-Secretase inhibitor.

    ≥98%
  • P9768

    Pyronaridine Tetraphosphate

    Hemantin inhibitor.

    ≥98%
  • A761001

    AT-7519 free base

    ATP competitive CDK inhibitor.

    ≥98%
  • D5792

    Doxofylline

    Xanthine derivative; PDE inhibitor.

    ≥98%
  • A480010

    AM630

    CB2 receptor antagonist.

    ≥97%
  • L0528

    LBH-589

    HDAC1/2/3/11 inhibitor.

    ≥98%
  • K9858

    Kyotorphin

    Opioid neuropeptide; kyotorphin agonist.

    ≥95%
  • N8663

    NVP-LDE225 Diphosphate

    Smo inhibitor.

    ≥98%
  • H1662

    HER2/neu (654-662) GP2

    Peptide fragment of HER2/neu/erbB2 receptor.

    ≥95%
  • T3584

    Tivantinib

    MET and GSK-3α/β inhibitor.

    ≥98%
  • F1854

    Fenticonazole Nitrate

    Imidazole; 14-α demethylase inhibitor, potenti...

    ≥98%
  • M324083

    Micafungin

    Echinocandin

    ≥95%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
  • Privacy Policy
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only